ELIEM THERAPEUTICS INC (ELYM)

US28658R1068 - Common Stock

8.25  +0.07 (+0.86%)

After market: 8.25 0 (0%)

News Image
4 days ago - InvestorPlace

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024

Eliem Therapeutics just reported results for the first quarter of 2024.

News Image
16 days ago - Chartmill

Which stocks are experiencing notable movement on Friday?

Which stocks are experiencing notable movement on Friday?

News Image
16 days ago - Chartmill

Which stocks are moving on Friday?

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

News Image
19 days ago - Chartmill

What's going on in today's session

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

News Image
19 days ago - Chartmill

Which stocks are moving on Tuesday?

Which stocks are experiencing notable movement on Tuesday?

News Image
a month ago - Kaskela Law LLC

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm

/PRNewswire/ -- Kaskela Law LLC, announces that it is investigating Eliem Therapeutics, Inc. (NASDAQ: ELYM) ("Eliem") on behalf of the company's shareholders....

News Image
a month ago - Kuehn Law, PLLC

Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm

/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...

News Image
a month ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODN

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
a month ago - Eliem Therapeutics, Inc.

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have...

News Image
a month ago - InvestorPlace

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023

Eliem Therapeutics just reported results for the fourth quarter of 2023.

News Image
a month ago - BusinessInsider

ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Eliem Therapeutics (NASDAQ:ELYM) just reported results for the fourth quarter o...

News Image
10 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!

News Image
10 months ago - InvestorPlace

Why Is BioSig Technologies (BSGM) Stock Up 19% Today?

BioSig Technologies (BSGM) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NVDA) Inception program.

News Image
10 months ago - InvestorPlace

Why Is Discover Financial (DFS) Stock Down 13% Today?

Discover Financial (DFS) stock is falling on Thursday after the financial services company revealed it's undergoing a regulatory review.

News Image
10 months ago - InvestorPlace

Why Is Netcapital (NCPL) Stock Down 42% Today?

Netcapital (NCPL) stock is dropping on Thursday after the fintech company announced the pricing of a public share offering.

News Image
10 months ago - InvestorPlace

Why Is Eliem Therapeutics (ELYM) Stock Up 6% Today?

Eliem Therapeutics (ELYM) stock is taking off on Thursday after the biotechnology company announced plans to explore strategic alternatives.

News Image
10 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning!

News Image
10 months ago - Eliem Therapeutics, Inc.

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM) today announced that it has completed a...

News Image
a year ago - Eliem Therapeutics, Inc.

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

Presented initial preclinical data from ETX-123, Eliem's lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed...

News Image
a year ago - Eliem Therapeutics, Inc.

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights

Progressing IND-enabling studies for ETX-123 and further preclinical development of Kv7.2/3 channel opener program Implemented corporate reorganization...